Enterobacter sakazakii Infections

Clinical Consequences of Enterobacter sakazakii Infections

John Alexander, M.D., M.P.H.

Division of Anti-Infective Drug Products,

Center for Drug Evaluation and Research, FDA

Outline

  • Neonatal Meningitis
  • Necrotizing Enterocolitis
  • Bacteremia/Sepsis

Neonatal Meningitis

  • Incidence: 0.25-1/1000 Live Births
  • Usual Pathogens:
    • Group B Streptococcus
    • Escherichia coli
    • Listeria monocytogenes
  • Enterobacterspp. < 4% of One Survey
    • Rare Organism in a Rare Disease

Neonatal Meningitis

  • Clinical Manifestations
    • Non-Specific Findings
      • Fever/Temperature Instability
      • Lethargy/Poor Feeding
      • Respiratory Distress
    • Specific Findings (Infrequent)
      • Bulging Fontanelle
      • Stiff Neck/Opisthotonus
      • Convulsions

Neonatal Meningitis

  • E. sakazakii
    • Based on Collected Literature
    • 55% of Neonates < 2500g
    • 50% of Pediatric Cases < 1 Week of Age
    • Almost 75% < 1 Month of Age

Lai KK, Medicine 2001; 80(2):113-22

Burdette et al., Pediatric Radiology

(2000) 30:33-34

Neonatal Meningitis

  • Outcome
    • 17% Case Fatality Rate for Gram (-) Meningitis
    • 45% for E. sakazakii Meningitis from Reports
  • Therapy
    • At least 3 weeks of IV Antibiotics
    • Longer for Persistent (+) Cultures

Neonatal Meningitis

  • Sequelae of Gram (-) Meningitis in 58%
    • Developmental Delay (37%)
    • Seizure Disorder (36%)
    • Cerebral Palsy (31%)
    • Hydrocephalus (27%)
    • Hearing Loss (17%)

Unhanand M et al., J Pediatrics 1993; 122(1): 15-21

Necrotizing Enterocolitis

  • Disease of the GI Tract
  • Mostly in Pre-Term Infants
    • Approximately 10% of Affected Infants are Term Infants*
    • Up to 10% of NICU Admissions*
  • Multifactorial Disease
  • Outbreak – Association with Infection

*Fanaroff and Martin: Neonatal-Perinatal Medicine, 7th edition, 2002.

Necrotizing Enterocolitis

  • Bacteria
    • Coagulase-Negative Staphylococci, Escherichia coli (including ETEC), Enterobacter spp., Klebsiella spp., Pseudomonas aeruginosa, Salmonella spp., Clostridium difficile, Clostridium perfringens, Clostridium butyricum
  • Viruses
    • Rotavirus, Coronavirus

Principles and Practice of Pediatric Infectious Diseases

Necrotizing Enterocolitis

  • Clinical Manifestations
    • Wide Spectrum of Disease
    • Sudden or Insidious Onset
    • Non-Specific Findings
      • Feeding intolerance, Temperature instability, Lethargy, Apnea, Respiratory Distress, Metabolic Acidosis, Glucose instability, Leukocytosis, Neutropenia, Thrombocytopenia, Shock
    • GI Findings
      • Abdominal distention, tenderness and/or erythema, Bilious emesis, Blood in stools (Visible or Microscopic), Disorganized bowel gas pattern, Pneumatosis Intestinalis, Portal Venous Gas, Pneumoperitoneum, Peritoneal Ascites

Necrotizing Enterocolitis

  • Therapy
    • Discontinue Feedings/Nasogastric Decompression
    • Serial Radiographic Examinations
    • Blood Culture and Antibiotics
    • IV Fluids/Supportive Care for Systemic Disease
    • Surgery for Advanced Disease (Roughly 20%)

Necrotizing Enterocolitis

  • Outcomes
    • Overall Mortality Rates due to NEC in Last Decade: 9-28% *
    • Survival 98% for Medical Management
    • Surgical Mortality Rate 45% ** (range up to 60%) *
      • Inversely Related to Gestational Age and Size
    • GI strictures 25%-35%, after Medical or Surgical Therapy *
    • GI Dysfunction (10%)
    • Neurodevelopmental Sequelae (15-33%)
    • Short Gut Syndrome

* Fanaroff and Martin: Neonatal-Perinatal Medicine, 7th edition, 2002.

** Grosfeld JL et al., J Pediatr Surg 1998 July;33(7):967-72

Bacteremia/Sepsis

  • Bacteremia – Bacteria in the Blood
    • Occurs with Many Infections
  • Meningitis and NEC
  • Sepsis – Clinical Syndrome
    • Shock, Fever, Systemic Illness
    • Associated with Morbidity and Mortality

Bacteremia/Sepsis

  • Opportunistic Pathogen
    • Neonate/Prematurity
      • Meningitis and NEC Cases;
      • 7 d/o with Fever/Sepsis; Hospitalized
    • Cancer/Central Line
      • 3 y/o Rhabdomyosarcoma; Recovered with Antibiotics and Line Removal
    • Altered Host Defense
      • 6 m/o Intestinal Resection; Recovered with Abx

Conclusions

  • Enterobacter sakazakii
    • Cause of Meningitis, NEC, Bacteremia
    • Serious Morbidity and Mortality
      • Especially in Neonatal Disease

Previous post:

Next post: